Notícias

In spite of the first glimmer of hope in weeks, the bad news continues to pile up for the stock market.

Stocks looked set to jump on Tuesday as investors bet that the U.S. and Iran were closing in on a peace deal to end the war in the Middle East. President Donald Trump wrote in a post on Truth Social on Monday that talks with Tehran were “proceeding nicely,” although he added that he was prepared to order more strikes against Iran. Later on Monday, the U.S. sank two Islamic Revolutionary Guard Corps ships attempting to lay mines in the Strait of Hormuz in what military officials described as defensive strikes, but investors weren’t too rattled by the flare-up in tensions.

Right now is a smart time to prepare your investments for potential volatility.

The Dow is no longer dominated by industrial, energy, manufacturing, and consumer goods companies.

Investors are piling into stocks at a feverish pace. But by one measure, equities look as unattractive as they did after the dot-com bubble burst. That metric is the equity risk premium, often defined as the gap between the S&P 500’s earnings yield—the profit companies generate relative to stock valuations, expressed as a percentage—and that of the 10-year Treasury note.

Shares were mixed Tuesday in Europe and Asia after the U.S. military said it carried out what it called “self-defense” strikes in southern Iran, including on missile launch sites and boats placing mines. The attacks came even as President Donald Trump said on social media that negotiations on ending the war were “proceeding nicely.” In early European trading, Germany's DAX lost 0.7% to 25,214.08, while the CAC 40 in Paris shed 0.9% to 8,187.07.

Dow Jones futures rose after a long weekend as crude oil prices dived on Iran deal hopes despite U.S. strikes. Marvell, Dell, Costco earnings loom.

Vulcan Materials stock has underperformed the broader market over the past year, while analysts are cautiously bullish about its prospects.

The critics have missed out on substantial returns.

U.S. President Donald Trump said in a post on Truth Social on Monday that negotiations with Iran are proceeding nicely, even as the military conducted “self-defense strikes” on southern Iran.

The gap between the market’s earnings yield and bond yields has narrowed, a measure that has at times predicted subpar stock returns.

“U.S. forces conducted self-defense strikes in southern Iran today to protect our troops from threats posed by Iranian forces."

Wall Street is abuzz with next month's expected blockbuster debut of Elon Musk's rocket and satellite maker SpaceX, but few of the biggest IPOs in recent years have paid off for investors who bought in when the deals came to market. A Reuters analysis ‌of the 50 IPOs with the highest valuations in the past five years shows that investors would have been better off buying an S&P 500 ‌index fund about three-quarters of the time. An investor who bought each of the IPOs tracked ​by Reuters would be up an average of 27% through May 21.

Marvell (MRVL) stock closed the May 22 trading session at $196.33. The stock has rallied 131% year to date, by Sunday morning, May 24. Meanwhile, the SPDR S&P 500 index (SPY) is up about 9% in the same period. The company has outpaced the S&P 500, thanks to its participation in the broader ...

These leaders look very reasonably priced today.

Cathie Wood, chief of Ark Investment Management, likes to take advantage of IPOs. Cathie Wood, founder and CEO of Ark Investment Management, likes to jump into some of Wall Street’s hottest IPOs. In recent years, Wood’s Ark funds have bought shares of newly public companies, including ...

Federal Realty Investment Trust stock has performed in line with the broader market over the past year, while analysts remain moderately bullish about its prospects.

Intuit stock has largely underperformed the broader market over the past year, yet analysts remain highly bullish about its prospects.

The digital payments pioneer has been a huge disappointment for investors, as shares trade 86% below their record.

While Bio-Techne has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

The VistaShares Artificial Intelligence Supercycle ETF has earned a place on investors' lists.

Most dividend ETFs weren't ready for Nvidia's payout increase, but the WisdomTree U.S. Quality Dividend Growth Fund was.

Costco and Amazon will bounce back from the next market crash.

As Paychex has underperformed relative to the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Jim Cramer just refused to bless a portfolio built almost entirely on his own stock recommendations, and no question that the lesson is worth pausing on. On the May 22 episode of Mad Money, a caller named Jerry laid out a tech-saturated portfolio diversified across tech retail sales, software, semiconductors, data center, and advertising, noting ... The One Thing Jim Cramer Demands From Tech-Only Investors Before He’ll Bless the Strategy

Berkshire Hathaway's insurance float fuels investments as the company shifts to Japan trading houses and builds BHE renewables, backed by $370B+ cash.

(Bloomberg) -- Global stocks rose to record highs as crude oil fell after officials signaled the US was nearing a deal with Iran to reopen the Strait of Hormuz and restore oil flows. The dollar weakened.Most Read from BloombergNvidia CEO Urges Super Micro to Tighten Up on ComplianceTrump Doctor Visit Renews Health Scrutiny as 80th Birthday NearsTrump Says He’ll Announce Negotiated Deal With Iran ShortlyRubio Sees Good News Coming on Hormuz as Iran Talks ContinueUS, Iran Inch Toward Deal as Gaps

BE has surged 199% in 6 months as AI data centers fuel demand for its Energy Server, clean power and earnings estimates keep rising.

SYPR incurs a wider year-over-year net loss per share in Q1'26 as material shortages and manufacturing inefficiencies pressured margins, though defense and energy order growth support a more optimistic outlook.

IRIDEX posts a narrower year-over-year net loss per share in Q1'26 as strong glaucoma product sales and lower operating costs helped offset weakness in retina sales and supply-chain disruptions.